Search - tctmd.com

Displaying 121 - 140 of 4990

Sort: Relevancy | Date

Presentation TCT 2016

Choose a Drug-Eluting Stent: Heres Why

Presenter: George D. Dangas, Fabio Felice Tarantino, Carlo Cernetti

November 01, 2016

Presentation TCT 2016

TCT 1176: Calcified Aorto-Ostial Occlusion - A Terrible Combination for Chronic Total Occlusion

Presenter: Massoud A. Leesar, Adam Witkowski, Chi Hong Chau

November 01, 2016

Presentation TCT 2016

TCT 1097: Successful Revascularization for Double-Vessel CTO

Presenter: M Chadi Alraies, Jose Armando Mangione, Dai-Yin Lu

November 01, 2016

Presentation TCT 2016

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Vladimir Ganyukov

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Introduction: How Should I Treat?

Presenter: Runlin Gao, Bo Xu, Junjie Zhang

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did I Treat?

Presenter: Runlin Gao, Bo Xu, Kefei Dou

November 01, 2016

Presentation TCT 2016

BRS Bifurcation Rapid-Fire Case Reviews

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Manuel Pan

November 01, 2016

Presentation TCT 2016

Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience

Presenter: Christopher E. Buller, Masahisa Yamane, Kambis Mashayekhi

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Bifurcations and BRS: Techniques, Full Polymer, or Hybrid?

Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Azeem Latib

November 01, 2016

Presentation TCT 2016

TCT 1128: A Very Complicated Coronary Perforation

Presenter: Massoud A. Leesar, Adam Witkowski, Li-Wah Tam

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 2)

Presenter: Runlin Gao, Bo Xu, Zening Jin

November 01, 2016

Presentation TCT 2016

How Would I Treat? (Option 1)

Presenter: Runlin Gao, Bo Xu, Philippe Généreux

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

Presenter: Jonathan M. Hill, Christoph K. Naber, Azeem Latib

November 01, 2016

Presentation TCT 2016

TCT 1055: Retrograde Treatment of a Flush Right Coronary Artery Chronic Total Occlusion

Presenter: M Chadi Alraies, Jose Armando Mangione, Judit Karacsonyi

November 01, 2016

Presentation TCT 2016

Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience

Presenter: Christopher E. Buller, Masahisa Yamane, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

Case Presentation: ACS Intervention in the Emerging BRS Era

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Evgeny V. Merkulov

November 01, 2016

Advertisement

Choose a Drug-Eluting Stent: Heres Why

TCT 1176: Calcified Aorto-Ostial Occlusion - A Terrible Combination for Chronic Total Occlusion

TCT 1097: Successful Revascularization for Double-Vessel CTO

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Introduction: How Should I Treat?

Case Conclusion: How Did I Treat?

BRS Bifurcation Rapid-Fire Case Reviews

Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience

Case Conclusion: How Did We Treat Our Patient?

Bifurcations and BRS: Techniques, Full Polymer, or Hybrid?

TCT 1128: A Very Complicated Coronary Perforation

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

How Would I Treat? (Option 2)

How Would I Treat? (Option 1)

To Pretreat or Not to Pretreat? The DUBIUS Trial

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples)

TCT 1055: Retrograde Treatment of a Flush Right Coronary Artery Chronic Total Occlusion

Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience

Case Presentation: ACS Intervention in the Emerging BRS Era

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content